MR Montage Resources Corporation

www.RothmanResearch.com provides members a complete scrutiny of the medical instruments & supplies industry with thorough research on Baxter International Inc. and Mindray Medical International Limited. Sign up now on www.rothmanresearch.com to access these free reports.

The global economic downturn has had mixed effects on the medical technology industry. The biggest disparity lies between companies that produce products for elective and non-elective procedures. Non-elective treatments remained fairly constant while patients considering elective procedures were less likely to visit their doctor. This divide was especially seen in orthopedic medical technology. Knee and hip replacements were down because people seemed willing to put off procedures because of high surgery costs. Orthopedic companies that released newer high cost products saw more success despite the decrease in patients.

Like the economic downturn, the health reform bill is also having mixed effects on the medical technology industry. The health reform bill will cover more people who, in turn, will need more access to medical devices and technology. However, a greater emphasis on efficiency could offset the increase in patients. The reform bill is aimed at reducing redundant visits to imaging, diagnostic and screening machines. A 2.3% excise tax on medical devices set to begin in 2013 is also included in the reform bill. The tax will be on devices that ship domestically in non-retail settings. Early estimates show that that this could cost the industry up to $2.3 billion in the first year.

www.rothmanresearch.com is a source for investors seeking free information on medical instruments & supplies industry; investors and shareholders of Baxter International Inc., Mindray Medical International Limited and other companies in the industry are encouraged to sign up for free at http://www.rothmanresearch.com/index.php?id=6&name=Register.

In light of the challenges pressuring the industry, this quarter's earning seasons would be a good gauge of how well companies in this space are faring on a financial level. Baxter International Inc. (NYSE: BAX) earnings release yesterday even though at par with analysts estimates have been a major catalyst for drug stocks. This shows how expectations in the sector are very down-to-earth at this point in time. The company reported a 9% decline in its net income for this quarter due to elevated costs and a write-down of some accounts for an anticipated legal settlement. The legal settlement which would have provided the company with $22 million from Greece's government may never materialize due to the sovereign debt issues already plaguing the country. However, Baxter also announced a 2% revenue growth. www.rothmanresearch.com provides company and technical analysis with its free downloadable research report on Baxter International Inc. by registering now at http://www.rothmanresearch.com/article/bax/23719/Jul-23-2010.html

Mindray Medical International Limited (NYSE: MR), China's biggest medical equipment manufacturer, has scheduled its earnings release for August 9th. One key element making Mindray Medical attractive within this industry is the healthiness of its balance sheet. Complimentary report on Mindray Medical International Limited can be accessed at http://www.rothmanresearch.com/article/mr/23720/Jul-23-2010.html

Companies looking for additional media or advertising services can call Blue Chip IR at 1-917-267-8836

About Rothman Research

Rothman Research brings independent company and sector research together, utilizing top financial advisors and investment tactics to provide you with a clear picture of investment opportunities.

For More Information Contact: Jack Benassi info@rothmanresearch.com